Encapsulation of N-Diazeniumdiolates Within Liposomes for Enhanced Nitric Oxide Donor Stability and Delivery
Overview
Authors
Affiliations
The rapid decomposition of nitric oxide (NO) donors in aqueous environments remains a limitation for applications requiring extended NO release. Herein, we report the synthesis of dipalmitoylphosphatidylcholine-based liposomes capable of extended NO release using low molecular weight NO donors and a reverse-phase evaporation technique. The encapsulation of the NO donors within the liposomes enabled both prolonged NO release and enhanced storage compared to free NO donors alone. The NO-releasing liposomes also demonstrated enhanced efficacy against human pancreatic cancer cells. These NO-release vehicles represent attractive anticancer therapeutics due to their potential to store the majority of their NO payload until reaching cancerous tissue at which time the lower pH inherent to such environments will trigger an avalanche of NO.
Emerging nitric oxide gas-assisted cancer photothermal treatment.
Liang S, Liu Y, Zhu H, Liao G, Zhu W, Zhang L Exploration (Beijing). 2024; 4(6):20230163.
PMID: 39713202 PMC: 11655315. DOI: 10.1002/EXP.20230163.
Can Nitric Oxide-Based Therapy Be Improved for the Treatment of Cancers? A Perspective.
Sinha B Int J Mol Sci. 2023; 24(17).
PMID: 37686417 PMC: 10487592. DOI: 10.3390/ijms241713611.
Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications.
Andrabi S, Sharma N, Karan A, Shahriar S, Cordon B, Ma B Adv Sci (Weinh). 2023; 10(30):e2303259.
PMID: 37632708 PMC: 10602574. DOI: 10.1002/advs.202303259.
Nitric oxide in parasitic infections: a friend or foe?.
Omar M, Abdelal H J Parasit Dis. 2022; 46(4):1147-1163.
PMID: 36457767 PMC: 9606182. DOI: 10.1007/s12639-022-01518-x.
Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.
Kim J, Thomas S Pharmacol Rev. 2022; 74(4):1146-1175.
PMID: 36180108 PMC: 9553106. DOI: 10.1124/pharmrev.121.000500.